Are Allergies Hereditary?

Can You Inherit Allergies?

Allergies affect more than 500 million people worldwide and represent one of the most common chronic conditions in modern medicine. They range in severity from mild seasonal inconvenience to life-threatening anaphylaxis. But what determines who develops an allergy and who does not? The answer involves a complex interplay between your immune system, the environment you live in — and your genes.

Diet and environment both play important roles in allergy development, but so does genetics. Multiple well-designed studies have confirmed that allergies can be passed through genes. Children have approximately 50% higher odds of being allergic to a substance if one parent is allergic to it. If both parents are allergic to bee stings, that probability rises to approximately 75%.

Yet genetics is not destiny: even with two allergic parents, a child has a one-in-four chance of not developing the same allergy. And people can develop allergies with no family history at all. Understanding the role of heredity provides important context for prevention and early intervention — without suggesting that allergic disease is inevitable.

What Is an Allergy?

An allergy is an inappropriate immune response to a normally harmless substance — called an allergen. When a susceptible person's immune system encounters an allergen (such as pollen, peanut protein, cat dander, or bee venom), it mistakenly identifies it as a dangerous invader and mounts a defensive response. This involves the production of immunoglobulin E (IgE) antibodies specific to that allergen, the activation of mast cells and basophils, and the release of inflammatory mediators — primarily histamine — that produce the familiar symptoms of allergic disease.

The tendency to produce IgE antibodies in response to environmental allergens is called atopy, and it is the underlying predisposition shared by the major allergic conditions: hay fever (allergic rhinitis), asthma, eczema (atopic dermatitis), and food allergy. Atopy itself is strongly heritable — and it is largely the genetic predisposition to atopy, rather than predisposition to a specific allergy, that runs in families. A child who inherits atopic genes may develop hay fever like their mother or eczema like their father, rather than the exact same allergy as either parent.

The Genetics of Allergic Disease

Overall Heritability

Twin studies estimate the heritability of atopic conditions at 50–80%, depending on the specific condition. Asthma has a heritability of approximately 60–70%; atopic dermatitis around 70–80%; allergic rhinitis around 50–60%; and food allergy around 60–80%. These are substantial genetic contributions, comparable to or higher than many widely recognized "genetic diseases."

Large-scale genome-wide association studies (GWAS) have identified dozens of genetic loci associated with allergic conditions. As with most complex traits, no single gene determines allergy risk — it is the cumulative effect of many variants, each contributing modestly, combined with environmental exposures.

Key Genetic Loci

Some of the most consistently identified genetic regions associated with allergic disease include:

HLA region (chromosome 6p21): The HLA-DR and HLA-DQ loci, which encode proteins that present antigens to T cells, are strongly associated with both food allergies and respiratory allergies. These same HLA variants that help fight infection also influence the specificity of IgE responses to allergens. In peanut allergy, studies from Johns Hopkins Bloomberg School of Public Health found that HLA-DR and HLA-DQ regions are directly linked to peanut sensitization.
FCER1A (chromosome 1q23): Encodes the alpha subunit of the high-affinity IgE receptor on mast cells and basophils — the receptor that, when crosslinked by allergen-bound IgE, triggers the allergic response. Variants that increase FCER1A expression are associated with higher total IgE levels and increased allergy risk.
IL4 and IL13 (chromosome 5q31): Interleukin-4 and interleukin-13 are cytokines central to the Th2 immune response — the arm of adaptive immunity that drives IgE production and allergic inflammation. Variants in these genes and their shared receptor (IL4RA) are among the most replicated genetic findings in asthma and atopic disease.
FLG (chromosome 1q21): Loss-of-function mutations in filaggrin — a protein essential for skin barrier function — are strongly associated with atopic dermatitis and are a major predisposing factor for food allergy. When the skin barrier is defective, allergens can penetrate through the skin rather than the gut, leading to sensitization via a route that is particularly prone to generating IgE responses.
TSLP (chromosome 5q22): Thymic stromal lymphopoietin is an epithelial cytokine that acts as an early alarmin signal, activating dendritic cells and driving Th2 polarization. Variants in TSLP are associated with asthma, eczema, and food allergy, reflecting its upstream role in initiating allergic immune responses at epithelial barriers.

Are Food Allergies Hereditary?

Like other allergy types, food allergies arise from a combination of genetic predisposition and environmental triggers. A comprehensive review of studies published through the National Institutes of Health (NIH) analyzed the genetic mechanisms contributing to food allergies and concluded that a heritable component is evident across multiple study designs and populations.

Peanut Allergy

Peanut allergy is one of the most severe and persistent food allergies, and it has been among the most extensively studied. Research from the Johns Hopkins Bloomberg School of Public Health found that the HLA-DR and HLA-DQ regions are directly linked to peanut allergy risk. Further studies have identified variants in FLG (skin barrier), FCER1A (IgE receptor), and HLA-DQA1 as specific peanut allergy susceptibility loci.

The family aggregation data for peanut allergy is striking: individuals with a first-degree relative who has a peanut allergy have approximately 14 times higher odds of developing a peanut allergy themselves, compared to the general population. This extraordinary familial risk reflects both the shared genetic susceptibility and the shared early-life environmental exposures within families.

Cow's Milk and Other Food Allergies

Cow's milk allergy is the most common food allergy in young children worldwide. Its genetic component illustrates an important principle: the genetic risk for food allergy varies dramatically across populations, reflecting differences in both allele frequencies and environmental exposures. While fewer than 1% of children in Israel have cow's milk allergy, more than 10% of children in Australia are allergic to cow's milk — a difference that cannot be explained by genetics alone, since global genetic variation is modest over such short evolutionary time periods.

These population differences are now understood to reflect the importance of timing and route of allergen exposure — the "dual allergen exposure hypothesis" proposes that early oral exposure to food allergens (through eating) promotes tolerance, while early skin exposure (particularly through an impaired skin barrier) promotes sensitization. Environmental factors that differ between Israel and Australia — including complementary feeding practices and sun exposure affecting vitamin D status — likely account for much of the observed difference.

Symptoms of Allergic Reactions

Allergic symptoms can develop within minutes to two hours after exposure to the triggering allergen. The range of possible symptoms includes:

Tingling, itching, or swelling of the mouth and throat
Hives (urticaria) and eczema flares
Swelling of the face, tongue, lips, or throat (angioedema)
Wheezing, shortness of breath, and nasal congestion
Nausea, vomiting, diarrhea, and abdominal pain
Dizziness, lightheadedness, or loss of consciousness

Anaphylaxis is the most severe and life-threatening allergic reaction. It involves simultaneous involvement of multiple organ systems, including airway constriction, a rapid drop in blood pressure (anaphylactic shock), rapid pulse, and potentially loss of consciousness. Without prompt treatment with epinephrine (adrenaline), anaphylaxis can be fatal. Anyone with a known severe allergy should carry an epinephrine auto-injector (EpiPen) and have a written emergency action plan.

The Epigenetics of Allergy: Environment Writes on Genes

Beyond the fixed sequence of DNA, epigenetic mechanisms — changes in gene expression that do not alter the DNA sequence itself — play an important role in allergy development. Epigenetic marks (DNA methylation, histone modifications) can be influenced by environmental exposures and, in some cases, can even be transmitted across generations.

Studies have shown that maternal diet, antibiotic exposure, urban versus rural upbringing, microbiome composition, and smoke exposure during pregnancy can all influence the epigenetic regulation of immune genes in offspring — modifying allergy risk independently of inherited DNA sequence. This partly explains the "hygiene hypothesis": the observation that children raised in environments with greater microbial diversity and reduced antibiotic exposure tend to have lower allergy rates, despite similar genetic backgrounds.

The practical implication is that genetic risk for allergy is not immutable. Environmental interventions during critical windows of immune development — particularly the prenatal period and the first years of life — can substantially modify the trajectory from genetic risk to allergic disease.

Skin Testing Versus DNA Testing for Allergy Risk

Traditional allergy skin prick tests and specific IgE blood tests are the clinical gold standard for confirming sensitization to known allergens. They are highly accurate for diagnosing established allergic disease. However, they have limitations: they expose the patient to the allergen (small risk of reaction), they are not appropriate for all individuals (including very young children or those on certain medications), and they test for sensitization that is already present — they do not predict future risk before sensitization develops.

DNA-based testing for allergy risk offers a complementary perspective:

Non-invasive and painless — requires only a saliva or cheek swab sample
No risk of triggering an allergic reaction
Can be performed at any age, including in infants before any sensitization has occurred
Provides information about genetic predisposition across a broad range of potential allergens
Can identify individuals at elevated risk before symptoms develop, enabling proactive prevention strategies
Generally more cost-effective than comprehensive clinical allergy panels

How Do DNA Tests Assess Allergy Risk?

DNA tests for allergy risk are not diagnostic — they do not confirm that you have a specific allergy today, nor do they replace clinical evaluation. Rather, they reveal your genetic susceptibility or predisposition to developing allergic conditions based on the variants you carry in allergy-associated genes.

Results from well-designed genetic allergy reports can include:

Your polygenic risk score for atopic disease (reflecting the cumulative effect of many allergy-associated variants)
Information about specific high-impact variants (such as FLG loss-of-function mutations) that substantially elevate risk for eczema and food allergy
Population-contextualized risk estimates that account for your ancestry
Guidance on how to recognize early allergy symptoms
Evidence-based preventive strategies relevant to your risk profile
Recommendations regarding further clinical testing when genetically elevated risk is identified

DNA testing can also illuminate genetic associations with autoimmune conditions and immune hypersensitivity disorders more broadly. Understanding more about how your immune system is genetically configured gives you the opportunity to make informed decisions — about early allergen introduction strategies for your children, about monitoring for early signs of eczema or asthma, and about when to seek specialist evaluation.

Prevention Strategies for High-Risk Individuals

Knowing that you or your child carries a genetic predisposition to allergic disease enables proactive prevention steps that have real evidence behind them:

Early allergen introduction: landmark studies (LEAP, EAT) have demonstrated that introducing allergenic foods (including peanut) in the first year of life — while the infant's immune system is still in a tolerogenic state — dramatically reduces the risk of developing food allergy. This represents one of the most impactful public health findings in allergy in recent decades.
Skin barrier protection: for infants with FLG mutations or early eczema, regular emollient use from birth may help maintain skin barrier integrity and reduce sensitization through the skin.
Breastfeeding and diet: breastfeeding, maternal diet during pregnancy and lactation, and the timing of complementary food introduction all influence allergy risk.
Microbiome support: maintaining diverse gut and skin microbiota through diverse diet, limited unnecessary antibiotic use, and exposure to natural environments may reduce allergy risk.

What helixXY Can Reveal

Through your raw genetic data, helixXY analyzes variants in key immune regulation genes — including HLA loci, FLG, FCER1A, IL4, IL13, TSLP, and others — to assess your genetic predisposition to allergic conditions. Our reports provide contextualized risk information, practical guidance, and signposting toward further evaluation when appropriate.

If you are a parent with food allergies, genetic testing can provide reassurance alongside honest risk information. While it is possible to pass allergy-predisposing genes to your children, having a higher genetic risk does not guarantee that your child will develop the same allergy. Armed with genetic information, you and your healthcare team can implement the most evidence-based preventive strategies available.

Important disclaimer: helixXY reports are informational and educational. They are not a substitute for clinical allergy testing or medical evaluation. If you or your child experience allergic symptoms — particularly any symptoms suggesting anaphylaxis — seek immediate medical attention. Do not alter any current treatment or avoidance plan based solely on a consumer genetic report. Discuss your results with your physician or allergist.

References

Sicherer SH, Sampson HA. Food allergy: epidemiology, pathogenesis, diagnosis, and treatment. J Allergy Clin Immunol. 2014;133(2):291–307.
Ferreira MA, et al. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nature Genetics. 2017;49(12):1752–1757.
Muraro A, et al. EAACI guidelines on allergen immunotherapy: food allergy. Allergy. 2018;73(4):819–843.
Du Toit G, et al. (LEAP Study Team). Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372(9):803–813.
Palmer CN, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics. 2006;38(4):441–446.
NIH National Institute of Allergy and Infectious Diseases. niaid.nih.gov